Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Impact of apolipoprotein E genetic polymorphisms on liver disease: An essential review.

Nascimento JCR, Matos GA, Pereira LC, Mourão AECCB, Sampaio AM, Oriá RB, Toniutto P.

Ann Hepatol. 2019 Sep 11. pii: S1665-2681(19)32218-5. doi: 10.1016/j.aohep.2019.07.011. [Epub ahead of print] Review.

2.

[New organ allocation criteria in liver transplantation.]

Toniutto P, Fornasiere E, Fumolo E, Bitetto D.

Recenti Prog Med. 2018 Dec;109(12):609-613. doi: 10.1701/3082.30747. Review. Italian.

PMID:
30667392
3.

HepaDisk - A new quality of life questionnaire for HCV patients.

Fagiuoli S, Caporaso N, Morisco F, Buelli F, Gualberti G, Saragaglia V, Chessa L, Corti G, Maida I, Mastroianni CM, Pirisi M, Russo FP, Farina F, Giannitrapani L, Toniutto P, Tarquini P, Tundo P, Vecchiet J, Vinci M, Taliani G; HepaDisk Study Group.

Dig Liver Dis. 2019 Jul;51(7):1008-1015. doi: 10.1016/j.dld.2018.12.009. Epub 2018 Dec 23.

4.

Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.

Dissegna D, Sponza M, Falleti E, Fabris C, Vit A, Angeli P, Piano S, Cussigh A, Cmet S, Toniutto P.

Eur J Gastroenterol Hepatol. 2019 May;31(5):626-632. doi: 10.1097/MEG.0000000000001342.

PMID:
30550458
5.

Challenges and future developments in liver transplantation.

Toniutto P, Bitetto D, Fornasiere E, Fumolo E.

Minerva Gastroenterol Dietol. 2019 Jun;65(2):136-152. doi: 10.23736/S1121-421X.18.02529-1. Epub 2018 Oct 5.

PMID:
30303340
6.

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.

Caraceni P, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A, Boccia S, Svegliati-Baroni G, Fagiuoli S, Romanelli RG, Cozzolongo R, Di Marco V, Sangiovanni V, Morisco F, Toniutto P, Tortora A, De Marco R, Angelico M, Cacciola I, Elia G, Federico A, Massironi S, Guarisco R, Galioto A, Ballardini G, Rendina M, Nardelli S, Piano S, Elia C, Prestianni L, Cappa FM, Cesarini L, Simone L, Pasquale C, Cavallin M, Andrealli A, Fidone F, Ruggeri M, Roncadori A, Baldassarre M, Tufoni M, Zaccherini G, Bernardi M; ANSWER Study Investigators.

Lancet. 2018 Jun 16;391(10138):2417-2429. doi: 10.1016/S0140-6736(18)30840-7. Epub 2018 Jun 1. Erratum in: Lancet. 2018 Aug 4;392(10145):386.

PMID:
29861076
7.

Specific issues concerning the management of patients on the waiting list and after liver transplantation.

Burra P, Giannini EG, Caraceni P, Ginanni Corradini S, Rendina M, Volpes R, Toniutto P.

Liver Int. 2018 Aug;38(8):1338-1362. doi: 10.1111/liv.13755. Epub 2018 May 16. Review.

PMID:
29637743
8.

[Hepatitis C virus infection. From clinical guidelines to clinical practice and personalization of cure.]

Toniutto P.

Recenti Prog Med. 2018 Jan;109(1):33-37. doi: 10.1701/2848.28752. Italian.

PMID:
29451520
9.

Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohort.

Marzano A, Andreone P, Boccagni P, Burra P, Caneschi F, Conoscitore PF, Coppola C, DE Carlis L, Fagiuoli S, Forte P, Gaeta GB, Iemmolo RM, Lotti Suffredini A, Mazzola M, Merli M, Parrilli G, Piai G, Piras MR, Salizzoni M, Tamè M, Tisone G, Toniutto P, Vennarecci G, Volpes R, Zamboni F, Caccamo L; ISPHeB group.

Minerva Gastroenterol Dietol. 2018 Mar;64(1):1-9. doi: 10.23736/S1121-421X.17.02407-2.

PMID:
29307146
10.

Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.

Kondili LA, Gaeta GB, Ieluzzi D, Zignego AL, Monti M, Gori A, Soria A, Raimondo G, Filomia R, Di Leo A, Iannone A, Massari M, Corsini R, Gulminetti R, Gatti Comini A, Toniutto P, Dissegna D, Russo FP, Zanetto A, Rumi MG, Brancaccio G, Danieli E, Brunetto MR, Weimer LE, Quaranta MG, Vella S, Puoti M.

PLoS One. 2018 Jan 2;13(1):e0190803. doi: 10.1371/journal.pone.0190803. eCollection 2018.

11.

Acute alcoholic hepatitis and liver transplantation: Waiting for Godot.

Toniutto P, Zanetto A, Ferrarese A, Burra P.

Liver Int. 2017 Sep;37(9):1408. doi: 10.1111/liv.13461. No abstract available.

PMID:
28845615
12.

The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes.

Carrai P, Morelli C, Cordone G, Romano A, Tamé M, Lionetti R, Pietrosi G, Lenci I, Piai G, Russo FP, Coppola C, Melazzini M, Montilla S, Pani L, Petraglia S, Russo P, Trotta MP, Martini S, Toniutto P; ITACOPS study group.

Transpl Int. 2017 Dec;30(12):1253-1265. doi: 10.1111/tri.13018. Epub 2017 Sep 7.

13.

Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis.

Vukotic R, Conti F, Fagiuoli S, Morelli MC, Pasulo L, Colpani M, Foschi FG, Berardi S, Pianta P, Mangano M, Donato MF, Malinverno F, Monico S, Tamè M, Mazzella G, Belli LS, Viganò R, Carrai P, Burra P, Russo FP, Lenci I, Toniutto P, Merli M, Loiacono L, Iemmolo R, Degli Antoni AM, Romano A, Picciotto A, Rendina M, Andreone P; AISF-SOFOLT Study group.

J Viral Hepat. 2017 Oct;24(10):858-864. doi: 10.1111/jvh.12712. Epub 2017 May 5.

PMID:
28370880
14.

Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study.

Bassetti M, Peghin M, Carnelutti A, Righi E, Merelli M, Ansaldi F, Trucchi C, Alicino C, Sartor A, Toniutto P, Wauters J, Laleman W, Tascini C, Menichetti F, Luzzati R, Brugnaro P, Mesini A, Raviolo S, De Rosa FG, Lagunes L, Rello J, Dimopoulos G, Colombo AL, Nucci M, Vena A, Bouza E, Muñoz P, Tumbarello M, Losito R, Martin-Loeches I, Viscoli C.

Intensive Care Med. 2017 Apr;43(4):509-518. doi: 10.1007/s00134-017-4717-0. Epub 2017 Mar 7.

PMID:
28271321
15.

Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.

Kondili LA, Gaeta GB, Ieluzzi D, Zignego AL, Monti M, Gori A, Soria A, Raimondo G, Filomia R, Di Leo A, Iannone A, Massari M, Corsini R, Gulminetti R, Gatti Comini A, Toniutto P, Dissegna D, Russo FP, Zanetto A, Rumi MG, Brancaccio G, Danieli E, Brunetto MR, Weimer LE, Quaranta MG, Vella S, Puoti M.

PLoS One. 2017 Feb 28;12(2):e0172159. doi: 10.1371/journal.pone.0172159. eCollection 2017. Erratum in: PLoS One. 2018 Jan 2;13(1):e0190803.

16.

Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib.

Howell J, Pinato DJ, Ramaswami R, Arizumi T, Ferrari C, Gibbin A, Burlone ME, Guaschino G, Toniutto P, Black J, Sellers L, Kudo M, Pirisi M, Sharma R.

Oncotarget. 2017 May 30;8(22):36161-36170. doi: 10.18632/oncotarget.15322.

17.

Common issues in the management of patients in the waiting list and after liver transplantation.

Burra P, Belli LS, Ginanni Corradini S, Volpes R, Marzioni M, Giannini E, Toniutto P.

Dig Liver Dis. 2017 Mar;49(3):241-253. doi: 10.1016/j.dld.2016.12.027. Epub 2016 Dec 31. Review.

PMID:
28096056
18.

Consensus conference on TIPS management: Techniques, indications, contraindications.

Fagiuoli S, Bruno R, Debernardi Venon W, Schepis F, Vizzutti F, Toniutto P, Senzolo M, Caraceni P, Salerno F, Angeli P, Cioni R, Vitale A, Grosso M, De Gasperi A, D'Amico G, Marzano A; AISF TIPS Special Conference.

Dig Liver Dis. 2017 Feb;49(2):121-137. doi: 10.1016/j.dld.2016.10.011. Epub 2016 Oct 29.

PMID:
27884494
19.

Reply to the letter to the Editor.

Bignulin S, Falleti E, Cmet S, Cappello D, Cussigh A, Lenisa I, Dissegna D, Pugliese F, Vivarelli C, Fabris C, Toniutto P.

Ann Hepatol. 2016 Nov-Dec;15(6):947-948. No abstract available.

20.

Current challenges and future directions for liver transplantation.

Toniutto P, Zanetto A, Ferrarese A, Burra P.

Liver Int. 2017 Mar;37(3):317-327. doi: 10.1111/liv.13255. Epub 2016 Oct 2. Review.

PMID:
27634369
21.

Splenic Artery Syndrome as a Possible Cause of Late Onset Refractory Ascites After Liver Transplantation: Management With Proximal Splenic Artery Embolization.

Pravisani R, Baccarani U, Adani G, Lorenzin D, Vit A, Cherchi V, Calandra S, Rispoli I, Toniutto P, Sponza M, Risaliti A.

Transplant Proc. 2016 Mar;48(2):377-9. doi: 10.1016/j.transproceed.2016.01.013.

PMID:
27109959
22.

 Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplant.

Bignulin S, Falleti E, Cmet S, Cappello D, Cussigh A, Lenisa I, Dissegna D, Pugliese F, Vivarelli C, Fabris C, Fabris C, Toniutto P.

Ann Hepatol. 2016 Mar-Apr;15(2):200-6. doi: 10.5604/16652681.1193710.

23.

Reply to the letter to the Editor.

Bignulin S, Falleti E, Cmet S, Cappello D, Cussigh A, Lenisa I, Dissegna D, Pugliese F, Vivarelli C, Fabris C, Toniutto P.

Ann Hepatol. 2016 Nov - Dec;15(6):947-948. doi: 10.5604/16652681.1222120. No abstract available.

24.

Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplant.

Bignulin S, Falleti E, Cmet S, Cappello D, Cussigh A, Lenisa I, Dissegna D, Pugliese F, Vivarelli C, Fabris C, Toniutto P.

Ann Hepatol. 2016 Mar - Apr;15(2):200-206. doi: 10.5604/16652681.1193710.

25.

PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis.

Falleti E, Cussigh A, Cmet S, Fabris C, Toniutto P.

Dig Liver Dis. 2016 Jan;48(1):69-75. doi: 10.1016/j.dld.2015.09.009. Epub 2015 Sep 28.

PMID:
26493626
26.

A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a "Blended Principle Model".

Cillo U, Burra P, Mazzaferro V, Belli L, Pinna AD, Spada M, Nanni Costa A, Toniutto P; I-BELT (Italian Board of Experts in the Field of Liver Transplantation).

Am J Transplant. 2015 Oct;15(10):2552-61. doi: 10.1111/ajt.13408. Epub 2015 Aug 14.

27.

Corrigendum: PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease.

Salameh H, Raff E, Erwin A, Seth D, Nischalke HD, Falleti E, Burza MA, Leathert J, Romeo S, Molinaro A, Corradini SG, Toniutto P, Ulrich S, Daly A, Day CP, Kuo YF, Singal AK.

Am J Gastroenterol. 2015 Jul;110(7):1121. doi: 10.1038/ajg.2015.181. No abstract available.

PMID:
26148270
28.

Protease inhibitors-based therapy induces acquired spherocytic-like anaemia and ineffective erythropoiesis in chronic hepatitis C virus patients.

Lupo F, Russo R, Iolascon A, Ieluzzi D, Siciliano A, Toniutto P, Matté A, Piovesan S, Raffetti E, Turrini F, Dissegna D, Donato F, Alberti A, Zuliani V, Fattovich G, De Franceschi L.

Liver Int. 2016 Jan;36(1):49-58. doi: 10.1111/liv.12900. Epub 2015 Jul 14.

PMID:
26104535
29.

PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease.

Salameh H, Raff E, Erwin A, Seth D, Nischalke HD, Falleti E, Burza MA, Leathert J, Romeo S, Molinaro A, Corradini SG, Toniutto P, Spengler U, Daly A, Day CP, Kuo YF, Singal AK.

Am J Gastroenterol. 2015 Jun;110(6):846-56. doi: 10.1038/ajg.2015.137. Epub 2015 May 12. Review. Erratum in: Am J Gastroenterol. 2015 Jul;110(7):1121. Ulrich, Spengler [corrected to Spengler, Ulrich].

PMID:
25964223
30.

Reply to: "Evidence supporting a beneficial role of vitamin D in chronic hepatitis C".

Kitson MT, Sarrazin C, Toniutto P, Roberts SK.

J Hepatol. 2015 Aug;63(2):531-2. doi: 10.1016/j.jhep.2015.04.012. Epub 2015 Apr 18. No abstract available.

31.

Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: A 5-year experience.

Baccarani U, Pravisani R, Luigi Adani G, Lorenzin D, Cherchi V, Toniutto P, Risaliti A.

Liver Transpl. 2015 Nov;21(11):1457-8. doi: 10.1002/lt.24146. Epub 2015 Oct 10. No abstract available.

32.

Cost-effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation.

Vitale A, Spolverato G, Burra P, De Feo TM, Belli L, Donato F, Baroni GS, Marianelli T, Picciotto A, Toniutto P, Bhoori S, Passigato N, Lucà MG, Russo FP, Cillo U, Fagiuoli S; Liver Transplantation NITp working group.

Transpl Int. 2015 Sep;28(9):1055-65. doi: 10.1111/tri.12591. Epub 2015 Apr 30.

33.

Relationship between vitamin D status and response to hepatitis C virus therapy.

Kitson MT, Sarrazin C, Toniutto P, Roberts SK.

Hepatology. 2015 Nov;62(5):1642-3. doi: 10.1002/hep.27797. Epub 2015 Apr 22. No abstract available.

PMID:
25808060
34.

Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial.

Cavallin M, Kamath PS, Merli M, Fasolato S, Toniutto P, Salerno F, Bernardi M, Romanelli RG, Colletta C, Salinas F, Di Giacomo A, Ridola L, Fornasiere E, Caraceni P, Morando F, Piano S, Gatta A, Angeli P; Italian Association for the Study of the Liver Study Group on Hepatorenal Syndrome.

Hepatology. 2015 Aug;62(2):567-74. doi: 10.1002/hep.27709. Epub 2015 Feb 13.

PMID:
25644760
35.

Predictors of endoscopic treatment outcome in the management of biliary complications after orthotopic liver transplantation.

Faleschini G, Vadalà di Prampero SF, Bulajic M, Baccarani U, Toniutto P, Panic N, Zoratti LM, Marino M, Zilli M.

Eur J Gastroenterol Hepatol. 2015 Feb;27(2):150-4. doi: 10.1097/MEG.0000000000000251.

PMID:
25486026
36.

Biliary strictures after liver transplantation: role of interleukin 28B genotypes in cyclosporine treated.

Toniutto P, Bitetto D, Falleti E, Vadalà S, Cmet S, Cussigh A, Bulajic M, Zilli M, Fabris C.

Int J Surg. 2014 Oct;12(10):1082-7. doi: 10.1016/j.ijsu.2014.09.004. Epub 2014 Sep 16.

37.

Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis.

Kitson MT, Sarrazin C, Toniutto P, Eslick GD, Roberts SK.

J Hepatol. 2014 Dec;61(6):1247-52. doi: 10.1016/j.jhep.2014.08.004. Epub 2014 Aug 15. Review.

PMID:
25135863
38.

Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C.

Ponziani FR, Viganò R, Iemmolo RM, Donato MF, Rendina M, Toniutto P, Pasulo L, Morelli MC, Burra P, Miglioresi L, Merli M, Di Paolo D, Fagiuoli S, Gasbarrini A, Pompili M; AISF RECOLT-C Group, Belli L, Gerunda GE, Marino M, Montalti R, Di Benedetto F, De Ruvo N, Rigamonti C, Colombo M, Rossi G, Di Leo A, Lupo L, Memeo V, Bringiotti R, Zappimbulso M, Bitetto D, Vero V, Colpani M, Fornasiere E, Pinna AD, Morelli MC, Bertuzzo V, De Martin E, Senzolo M, Ettorre GM, Visco-Comandini U, Antonucci G, Angelico M, Tisone G, Giannelli V, Giusto M.

Dig Liver Dis. 2014 May;46(5):440-5. doi: 10.1016/j.dld.2014.01.157. Epub 2014 Mar 11.

PMID:
24635906
39.

The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management.

Faloppi L, Scartozzi M, Bianconi M, Svegliati Baroni G, Toniutto P, Giampieri R, Del Prete M, De Minicis S, Bitetto D, Loretelli C, D'Anzeo M, Benedetti A, Cascinu S.

BMC Cancer. 2014 Feb 20;14:110. doi: 10.1186/1471-2407-14-110.

40.

VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.

Scartozzi M, Faloppi L, Svegliati Baroni G, Loretelli C, Piscaglia F, Iavarone M, Toniutto P, Fava G, De Minicis S, Mandolesi A, Bianconi M, Giampieri R, Granito A, Facchetti F, Bitetto D, Marinelli S, Venerandi L, Vavassori S, Gemini S, D'Errico A, Colombo M, Bolondi L, Bearzi I, Benedetti A, Cascinu S.

Int J Cancer. 2014 Sep 1;135(5):1247-56. doi: 10.1002/ijc.28772. Epub 2014 Feb 20.

41.

Management of infections pre- and post-liver transplantation: report of an AISF consensus conference.

Fagiuoli S, Colli A, Bruno R, Craxì A, Gaeta GB, Grossi P, Mondelli MU, Puoti M, Sagnelli E, Stefani S, Toniutto P, Burra P; 2011 AISF Single Topic Group.

J Hepatol. 2014 May;60(5):1075-89. doi: 10.1016/j.jhep.2013.12.021. Epub 2013 Dec 30.

42.

Recipient perioperative cholesterolaemia and graft cholesterol metabolism gene expression predict liver transplant outcome.

Ginanni Corradini S, Siciliano M, Parlati L, Molinaro A, Cantafora A, Poli E, Mennini G, Melandro F, Vestri AR, Merli M, Bianco P, Corsi A, Toniutto P, Bitetto D, Falleti E, Attili AF, Berloco P, Rossi M.

Liver Int. 2014 Aug;34(7):e290-301. doi: 10.1111/liv.12351. Epub 2013 Nov 20.

PMID:
24256518
43.

Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C.

Falleti E, Cmet S, Fabris C, Fattovich G, Cussigh A, Bitetto D, Ceriani E, Lenisa I, Dissegna D, Ieluzzi D, Rostello A, Pirisi M, Toniutto P.

PLoS One. 2013 Nov 14;8(11):e80764. doi: 10.1371/journal.pone.0080764. eCollection 2013.

44.

Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data.

Trépo E, Nahon P, Bontempi G, Valenti L, Falleti E, Nischalke HD, Hamza S, Corradini SG, Burza MA, Guyot E, Donati B, Spengler U, Hillon P, Toniutto P, Henrion J, Franchimont D, Devière J, Mathurin P, Moreno C, Romeo S, Deltenre P.

Hepatology. 2014 Jun;59(6):2170-7. doi: 10.1002/hep.26767. Epub 2014 Apr 25.

PMID:
24114809
45.

Management of infections in cirrhotic patients: report of a consensus conference.

Fagiuoli S, Colli A, Bruno R, Burra P, Craxì A, Gaeta GB, Grossi P, Mondelli MU, Puoti M, Sagnelli E, Stefani S, Toniutto P.

Dig Liver Dis. 2014 Mar;46(3):204-12. doi: 10.1016/j.dld.2013.07.015. Epub 2013 Sep 8.

PMID:
24021271
46.

Skills and requirements of a transplant hepatologist: board certification of the Italian Association for the Study of the Liver (AISF).

Burra P, Belli L, Fagiuoli S, Angelico M, Costa AN, Caraceni P, Toniutto P.

Dig Liver Dis. 2013 Dec;45(12):992-4. doi: 10.1016/j.dld.2013.04.014. Epub 2013 Jun 28.

PMID:
23816698
47.

Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma.

Italian Association for the Study of the Liver (AISF); AISF Expert Panel; AISF Coordinating Committee, Bolondi L, Cillo U, Colombo M, Craxì A, Farinati F, Giannini EG, Golfieri R, Levrero M, Pinna AD, Piscaglia F, Raimondo G, Trevisani F, Bruno R, Caraceni P, Ciancio A, Coco B, Fraquelli M, Rendina M, Squadrito G, Toniutto P.

Dig Liver Dis. 2013 Sep;45(9):712-23. doi: 10.1016/j.dld.2013.01.012. Epub 2013 Feb 23.

48.

Sorafenib: from literature to clinical practice.

Di Marco V, De Vita F, Koskinas J, Semela D, Toniutto P, Verslype C.

Ann Oncol. 2013 Apr;24 Suppl 2:ii30-7. doi: 10.1093/annonc/mdt055. Review.

PMID:
23715941
49.

Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C.

Bitetto D, De Feo T, Mantovani M, Falleti E, Fabris C, Belli LS, Fagiuoli S, Burra P, Piccolo G, Donato MF, Toniutto P; AISF RECOLT Study Group, Cmet S, Cussigh A, Viganò R, Airoldi A, Pasulo L, Colpanij M, De Martin E, Gambato M, Rigamonti C.

Dig Liver Dis. 2013 Nov;45(11):927-32. doi: 10.1016/j.dld.2013.04.006. Epub 2013 May 27.

PMID:
23722013
50.

Reply: To PMID 22610885.

Falleti E, Fabris C, Toniutto P.

Hepatology. 2013 Nov;58(5):1864-5. doi: 10.1002/hep.26435. Epub 2013 Sep 13. No abstract available.

PMID:
23553733

Supplemental Content

Loading ...
Support Center